---
title: "R-One robotic platform given green light to enter Chinese market"
date: "2024-01-09T10:40:19.000Z"
publishedDate: "9 janvier 2024"
summary: "Robocath has announced the granting of a marketing authorisation to distribute its R-One robotic platform in China. The authorisation was issued on 8 December by the Chinese National Medical Products Administration (NMPA); making it the first vascular robotic platform to be granted approval in China."
importance: ""
sourceUrl: "https://cardiovascularnews.com/r-one-robotic-platform-given-green-light-to-enter-chinese-market/"
tags: ["France", "Actualité", "Cardiovascular News — Latest"]
permalink: "/papers/2024-01-09-r-one-robotic-platform-given-green-light-to-enter-chinese-market"
imageUrl: "https://cardiovascularnews.com/wp-content/uploads/sites/14/2022/01/Robocath-resize.jpg"
imageCredit: "Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/r-one-robotic-platform-given-green-light-to-enter-chinese-market/"
---

![R-One robotic platform given green light to enter Chinese market](https://cardiovascularnews.com/wp-content/uploads/sites/14/2022/01/Robocath-resize.jpg)

*Crédit image : Image de l’article — droits possiblement réservés — https://cardiovascularnews.com/r-one-robotic-platform-given-green-light-to-enter-chinese-market/*

## L’essentiel

Robocath has announced the granting of a marketing authorisation to distribute its R-One robotic platform in China. The authorisation was issued on 8 December by the Chinese National Medical Products Administration (NMPA); making it the first vascular robotic platform to be granted approval in China.

## Lien source

https://cardiovascularnews.com/r-one-robotic-platform-given-green-light-to-enter-chinese-market/
